SAGANA
VC Fund
Zürich, Switzerland
Sagana is a dedicated team of investors, thinkers, and doers, working to unleash the potential of people, capital and business to create a better future for all. Driven by this bold vision, we leverage decades of experience in private equity, impact investing and entrepreneurship to discover, invest in and grow companies that are successfullysolving some of the biggest challenges of our time.
- Total investments:
- 14
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries SAGANA invests in
Stages SAGANA invests in
Countries SAGANA invests in
Round sizes
Round size
- Seed
- $1.2M–$4.2M
- Series A
- $3M–$11M
- Series B
- $18M–$23M
Investment Focus
Industry
- Education 2 (14%)
- Health Care 2 (14%)
- Biotechnology 2 (14%)
- Sustainability 2 (14%)
- Financial Services 2 (14%)
Stage
- Seed 5 (36%)
- Series A 5 (36%)
- Series B 1 (7%)
- Series C 1 (7%)
- Debt Financing 1 (7%)
Country
- India 4 (29%)
- Kenya 1 (7%)
- France 1 (7%)
- Vietnam 1 (7%)
- Singapore 1 (7%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Ekko offers Earned Wage Access (EWA), allowing employees to access their earned wages at any time, rather than waiting for a certain payday. | $4.2M / Seed / Feb 03, 2026 | ||
| Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in waterconsumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com | $18M / Series B / Jun 23, 2025 | ||
| Promethean Energy is a waste heat recovery and water saving solution for industrial and commercial applications. It also develops systems to recover waste heat and reduce fuel consumption across industries such as chemicals, textiles, dairy, food, and hospitality, enabling clients to increase fuel efficiency and reduce their carbon footprint. | $2M / Seed / May 22, 2025 | ||
| Cancrie produces sustainable advanced material for energy storage devices. It transforms waste into quality advanced battery material that increases the efficiency of energy storage devices through a simple drop-in solution. | $1.2M / Seed / Jan 22, 2025 | ||
| inHEART delivers AI-enabled, digital twin of the heart to advance the care of patients living with cardiac disease. inHEART develops software solutions for medical image analysis and cardiac modeling in heart rhythm disorders. inHEART vision is to make the bridge between radiology and cardiology become an image-guided diagnosis, therapy planning,and navigation software solution for heart rhythm disorders. | $11M / Series A / May 06, 2024 | ||
| Meridia is an AgTech company specialised in software solutions for field data within complex agri-commodity supply chains.Meridia Verify®, a SaaS product, verifies supply chain field data against regulatory and voluntary sustainability frameworks in minutes and provides hands-on guidance for risk mitigation. Procurement and sustainability teamseliminate commercial and reputational risks, prevent supply chain disruptions, and shift from guesswork to confident, evidence-based decisions.Our mission is to improve the veracity of datasets that drive decision-making in global agri-commodity supply chains. Our purpose is to build transparent and inclusive supply chains. | $5.6M / Series A / Apr 23, 2024 | ||
| Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in waterconsumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com | $22.7M / Series B / May 27, 2022 | ||
| Homage provides non-medical and medical services to seniors and adults. Their services include disability assessments, activities of daily living assistance, nursing procedures, and rehabilitation services, including physiotherapy, speech therapy, and occupational therapy. They also provide health screening, mobile medicine, telemedicine,ambulance, and medication delivery services. | $29.8M / Series C / Sep 03, 2021 | ||
| Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in waterconsumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com | $6M / Series A / Jul 10, 2020 | ||
| Biosense is a medical engineering and design firm that develops revolutionary diagnostics. It is dedicated towards finding practical alternative technological solutions that improve the lives of its users and empower its customers in delivering quality healthcare services to people. Biosense is a group of young professionals who are motivatedtowards identifying and solving pertinent neglected problems that are affecting millions of people worldwide. Healthcare is one of the largest sectors in India, handled by both public and private players generating a major share of revenue as well as employment opportunities in the country. When it comes to economics of healthcare, a lot of uncertainty is encountered as majority expenditure is still handled in an out-of- pocket fashion in private centers as opposed to insurance which is more popular in the western world. What complicates this business is the compulsive need for presence of moral and ethical values in every aspect along with presenting affordable and quality services.When it comes to diagnostic services and handling the burden many primary healthcare centers routinely face, the need for rapid and precise testing can ease many aspects of diagnosing the condition, management and also follow-up schedules. These roadblocks have become manageable to a certain extent with the introduction of IT and the digitization of healthcare services in India. POCT or the Point-of- caretesting services mark one aspect of rapid testing solutions widely used today, though the need for a specially trained personnel cannot be overlooked here.Biosense offers ToucHb, a non-invasive diagnostic device for screening anaemia. Focused on research and development, it works to develop more devices. The company’s group of young professionals is motivated towards identifying and solving pertinent neglected problems that are affecting millions of people worldwide. Biosense was established in 2008 and is based in West Godavari, India. | Debt Financing / Feb 18, 2019 | ||
| See all 14 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does SAGANA invest in?
SAGANA invests primarily in Education, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 14 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is SAGANA's check size?
SAGANA typically joins rounds of $1.2M–$4.2M at Seed, $3M–$11M at Series A and $18M–$23M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SAGANA participates in.
When did SAGANA last invest?
The most recent investment recorded for SAGANA closed in Feb 2026. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
